Physician profile
Peter Helvie
NPI 1124480488
$13,880.17
in general payments reported to CMS, 2019-2025
10 companies · $2,051 in 2025
The $2,051 reported for 2025 was more than what a typical Adult Reconstructive Orthopaedic Surgery provider received nationally (typical 2025 total: $1,425).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $401 · 2022: $782 · 2023: $1,676 · 2024: $8,971 · 2025: $2,051.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $9,533 · Travel and Lodging: $1,889 · Food and Beverage: $1,276.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $9,532.50 |
| Travel and Lodging | $1,888.88 |
| Food and Beverage | $1,276.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $10,052.31 | 2023-2025 | Attune, Actis |
| Depuy Synthes Sales INC. | $2,906.43 | 2022-2025 | Attune, Actis, Va-Lcp |
| Stryker Corporation | $223.55 | 2021-2023 | Gmrs |
| Osteoremedies, LLC | $154.88 | 2022 | |
| Orthofix Medical, INC. | $134.04 | 2021 | |
| Zimmer Biomet Holdings, INC. | $99.65 | 2022 | |
| Heraeus Medical, LLC. | $96.13 | 2023 | Palacos |
| Medacta USA, INC. | $88.51 | 2022 | |
| Kci USA, INC. | $83.15 | 2021 | |
| Medtronic, INC. | $41.52 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Helvie listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.